Clinical trial
Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)
NCT02314403 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2015
- Completion date
- July 31, 2021
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.